Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, announced ...
Tu, H. and Huang, Y.Y. (2026) Progress in Quantitative Imaging Assessment of Dermatomyositis-Associated Interstitial Lung ...
PHocus enrollment completed in under 12 months from first patient dosed, representing a rapid enrollment pace in pulmonary hypertension ...
A simple 3-biomarker score meaningfully improves risk stratification for both prevalent and incident rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), supporting a targeted, ...
Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patients with systemic autoimmune rheumatic disease who develop interstitial lung disease ...
Patients with inflammatory bowel disease (IBD) had a significantly higher risk for developing interstitial lung disease (ILD) compared with the general population and siblings who do not have the ...
New findings reveal that rheumatoid arthritis (RA) disease activity significantly affects the severity of interstitial lung disease (ILD), both radiologically and physiologically, in patients with RA ...
In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results